Clinical trial
Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients
NCT01553435 is registered in ClinicalTrials.gov with King Abdullah International Medical Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients
- Lead sponsor
- King Abdullah International Medical Research Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2011
- Completion date
- Not reported
- Enrollment
- 36 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
analgesia tolerance, opioid tolerance, pain